| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |